Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

KalVista Pharmaceuticals, Inc. KALV

Full chart Compare
Set alert

Price alert · KALV

All alert types
27.00 USD 0.00 (+0.00%)

At closeJun 10, 2026, 4:00 PM EDT

26.99 -0.01 -0.04%

After hours · Jun 10, 4:00 PM ET

26.98 Day range 27.00
10.41 52-week range 27.00
YTD
+67.18%
1 year
+106.26%

Financial health

Altman Z-Score

-0.51 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -5.0×
FY 2017: -3.8×FY 2018: -6.3×FY 2019: -16.7×FY 2020: -6.7×FY 2021: -10.7×FY 2022: -3.8×FY 2023: -2.7×FY 2024: -3.3×FY 2025: -3.7×FY 2026: -5.0×
FY 2017 5y median -3.7× FY 2026
P/S 11.2×
FY 2017: 46.8×FY 2018: 11.8×FY 2019: 21.5×FY 2020: 15.3×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 11.2×
FY 2017 5y median 0.0× FY 2026
P/B -303×
FY 2017: 2.2×FY 2018: 3.6×FY 2019: 3.6×FY 2020: 2.3×FY 2021: 1.9×FY 2022: 1.7×FY 2023: 1.5×FY 2024: 2.0×FY 2025: 7.2×FY 2026: -303×
FY 2017 5y median 1.7× FY 2026
P/FCF -9.9×
FY 2017: -3.0×FY 2018: 10.9×FY 2019: -9.3×FY 2020: -4.3×FY 2021: -15.8×FY 2022: -3.9×FY 2023: -3.2×FY 2024: -4.7×FY 2025: -4.5×FY 2026: -9.9×
FY 2017 5y median -4.5× FY 2026
EV/EBITDA -4.9×
FY 2017: -1.8×FY 2018: -2.6×FY 2019: -10.7×FY 2020: -4.5×FY 2021: -7.5×FY 2022: -3.6×FY 2023: -2.1×FY 2024: -2.9×FY 2025: -3.4×FY 2026: -4.9×
FY 2017 5y median -3.4× FY 2026
EV/Sales 10.1×
FY 2017: 26.2×FY 2018: 5.8×FY 2019: 19.5×FY 2020: 14.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 10.1×
FY 2017 5y median 0.0× FY 2026
FCF Yield -10.1%
FY 2017: -33.8%FY 2018: 9.2%FY 2019: -10.8%FY 2020: -23.3%FY 2021: -6.3%FY 2022: -25.4%FY 2023: -30.9%FY 2024: -21.5%FY 2025: -22.4%FY 2026: -10.1%
FY 2017 5y median -22.4% FY 2026

Profitability

Gross Margin 91.7%
FY 2017: 99.2%FY 2018: 99.8%FY 2019: 99.8%FY 2020: -216.7%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 91.7%
FY 2017 5y median 0.0% FY 2026
Operating Margin -233.4%
FY 2017: -1485.3%FY 2018: -222.8%FY 2019: -184.9%FY 2020: -319.4%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: -233.4%
FY 2017 5y median 0.0% FY 2026
Net Margin -223.2%
FY 2017: -1236.9%FY 2018: -188.3%FY 2019: -129.1%FY 2020: -229.4%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: -223.2%
FY 2017 5y median 0.0% FY 2026
ROE 6060.0%
FY 2017: -59.4%FY 2018: -58.0%FY 2019: -21.5%FY 2020: -34.8%FY 2021: -18.0%FY 2022: -44.5%FY 2023: -57.7%FY 2024: -61.3%FY 2025: -192.3%FY 2026: 6060.0%
FY 2017 5y median -57.7% FY 2026
ROIC -58.9%
FY 2017: -71.3%FY 2018: -48.7%FY 2019: -29.8%FY 2020: -47.5%FY 2021: -22.0%FY 2022: -50.0%FY 2023: -65.5%FY 2024: -61.6%FY 2025: -90.6%FY 2026: -58.9%
FY 2017 5y median -61.6% FY 2026
ROA -49.0%
FY 2017: -54.2%FY 2018: -25.7%FY 2019: -17.6%FY 2020: -31.5%FY 2021: -17.0%FY 2022: -40.4%FY 2023: -50.7%FY 2024: -53.8%FY 2025: -73.2%FY 2026: -49.0%
FY 2017 5y median -50.7% FY 2026

Growth (YoY)

Revenue 0.0%
FY 2017: -29.5%FY 2018: 458.1%FY 2019: 92.1%FY 2020: -21.3%FY 2021: -100.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 FY 2026
Operating Income 8.6%
FY 2017: -47.2%FY 2018: 16.3%FY 2019: -59.4%FY 2020: -35.9%FY 2021: -42.9%FY 2022: -66.8%FY 2023: -14.8%FY 2024: -26.7%FY 2025: -33.9%FY 2026: 8.6%
FY 2017 FY 2026
EPS (diluted) 12.5%
FY 2017: 20.0%FY 2018: 20.3%FY 2019: 9.8%FY 2020: -18.8%FY 2021: -42.1%FY 2022: -44.2%FY 2023: 0.9%FY 2024: -3.3%FY 2025: -7.3%FY 2026: 12.5%
FY 2017 FY 2026
Free Cash Flow 45.7%
FY 2017: -80.7%FY 2018: 138.4%FY 2019: -510.1%FY 2020: -20.3%FY 2021: 32.8%FY 2022: -161.3%FY 2023: 3.3%FY 2024: -17.3%FY 2025: -71.0%FY 2026: 45.7%
FY 2017 FY 2026

Financial Health

Current Ratio 5.6×
FY 2017: 11.3×FY 2018: 2.6×FY 2019: 6.4×FY 2020: 11.5×FY 2021: 27.0×FY 2022: 16.7×FY 2023: 11.5×FY 2024: 9.9×FY 2025: 5.4×FY 2026: 5.6×
FY 2017 5y median 9.9× FY 2026
Quick Ratio 5.5×
FY 2017: 11.3×FY 2018: 2.6×FY 2019: 6.4×FY 2020: 11.5×FY 2021: 27.0×FY 2022: 16.7×FY 2023: 11.5×FY 2024: 9.9×FY 2025: 5.4×FY 2026: 5.5×
FY 2017 5y median 9.9× FY 2026
Debt / Equity -55.9×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.1×FY 2024: 0.0×FY 2025: 0.1×FY 2026: -55.9×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA 0.5×
FY 2017: 1.4×FY 2018: 2.7×FY 2019: 1.1×FY 2020: 0.4×FY 2021: 0.8×FY 2022: 0.3×FY 2023: 0.5×FY 2024: 0.2×FY 2025: 0.5×FY 2026: 0.5×
FY 2017 5y median 0.5× FY 2026
Interest Coverage -8.9×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -32.5×FY 2026: -8.9×
FY 2017 5y median 0.0× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2025-12-31